ARTA
LKFT

A.R.T. Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

A.R.T. Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,502
Closed -$517K – 423
2019
Q4 		$517K Buy
+2,502
New +$463K 0.03% 838
2019
Q1 		– Sell
-4,227
Closed -$388K – 1415
2018
Q4 		$388K Sell
4,227
-700
-14% -$71K 0.02% 824
2018
Q3 		$553K Buy
+4,927
New +$521K 0.03% 816
2016
Q2 		– Sell
-13,100
Closed -$547K – 1464
2016
Q1 		$547K Buy
+13,100
New +$608K 0.02% 825

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

A.R.T. Advisors's LKFT Position: Q1 2020 in Review

A.R.T. Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2020, closing a stake of 2,502 shares — an estimated $517K sold.

A.R.T. Advisors first reported a position in LKFT in Q1 2016 and held it in 4 quarters. The position peaked at $553K in Q3 2018. 141 funds tracked by Wall St. Rank hold LKFT as of Q1 2020.

  • A.R.T. Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 2,502 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2020, an estimated $517K.
  • A.R.T. Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2016 and held it in 4 quarters.
  • A.R.T. Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $553K in Q3 2018.
  • 141 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.